Free Trial

Mind Medicine (MindMed) (MNMD) News Today

Mind Medicine (MindMed) logo
$6.80 -0.14 (-1.95%)
As of 11:18 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Mind Medicine (MindMed) Inc. stock logo
Allostery Investments LP Invests $905,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Allostery Investments LP acquired a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 130,000 shares of the company's stock, valued at approximately $905,000. Mind Medicine (
Mind Medicine (MindMed) Inc. stock logo
Ally Bridge Group NY LLC Sells 458,233 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Ally Bridge Group NY LLC reduced its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 58.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 330,275 shares of the company's stock after selling 458,23
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (MNMD) to Release Earnings on Thursday
Mind Medicine (MindMed) (NASDAQ:MNMD) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-mind-medicine-mindmed-inc-stock/)
Mind Medicine (MindMed) Inc. stock logo
Tri Locum Partners LP Decreases Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Tri Locum Partners LP lowered its position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 50.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 820,793 shares of the c
Mind Medicine (MindMed) Inc. stock logo
Marshall Wace LLP Purchases 213,526 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Marshall Wace LLP grew its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,501,391 shares of the compa
Mind Medicine (MindMed) Inc. stock logo
Geode Capital Management LLC Acquires 45,386 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Geode Capital Management LLC lifted its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 2.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,723,088 shares of the compa
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Analysts
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned a consensus rating of "Buy" from the thirteen analysts that are currently covering the firm, MarketBeat reports. Ten research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the
Mind Medicine (MindMed) Inc. stock logo
Q1 Earnings Estimate for MNMD Issued By Leerink Partnrs
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Mind Medicine (MindMed) in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman anticipates that the company will post e
Mind Medicine (MindMed) Inc. stock logo
What is Chardan Capital's Forecast for MNMD FY2025 Earnings?
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at Chardan Capital issued their FY2025 earnings per share estimates for Mind Medicine (MindMed) in a report released on Monday, March 24th. Chardan Capital analyst R. Li anticipates that the company will earn ($1.70) per
Mind Medicine (MindMed) Inc. stock logo
BIT Capital GmbH Acquires New Shares in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
BIT Capital GmbH bought a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 63,405 shares of the company'
Mind Medicine (MindMed) Inc. stock logo
Carrie Liao Sells 2,347 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CAO Carrie Liao sold 2,347 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The shares were sold at an average price of $6.74, for a total transaction of $15,818.78. Following the transaction, the chief accounting officer now directly owns 144,923 shares in the company, valued at $976,781.02. The trade was a 1.59 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.
Mind Medicine (MindMed) Inc. stock logo
Insider Selling: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Sells 6,836 Shares of Stock
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Daniel Karlin sold 6,836 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The stock was sold at an average price of $6.74, for a total transaction of $46,074.64. Following the sale, the insider now owns 446,177 shares of the company's stock, valued at $3,007,232.98. This represents a 1.51 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $142,941.92 in Stock
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 21,208 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The shares were sold at an average price of $6.74, for a total value of $142,941.92. Following the completion of the sale, the chief executive officer now directly owns 856,556 shares of the company's stock, valued at $5,773,187.44. This trade represents a 2.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Analysts
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned a consensus rating of "Buy" from the thirteen research firms that are presently covering the company, Marketbeat.com reports. Ten research analysts have rated the stock with a buy recommendation and three have issued a strong
Mind Medicine appoints Matt Wiley as CCO
Mind Medicine (MindMed) Inc. stock logo
Wealthfront Advisers LLC Buys New Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Wealthfront Advisers LLC bought a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 103,086 shares of the company's stock, valued at approximately $717,000
Mind Medicine (MindMed) Inc. stock logo
What is HC Wainwright's Estimate for MNMD FY2029 Earnings?
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - HC Wainwright upped their FY2029 earnings estimates for Mind Medicine (MindMed) in a research note issued to investors on Friday, March 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn $2.86 per share for
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Cut to $16.00 by Analysts at Robert W. Baird
Robert W. Baird dropped their target price on shares of Mind Medicine (MindMed) from $27.00 to $16.00 and set an "outperform" rating for the company in a research report on Friday.
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Given Buy Rating at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Friday.
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS
Mind Medicine (MindMed) (NASDAQ:MNMD - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.08). During the same period in the prior year, the business posted ($0.59) earnings per share.
Psychedelic: MindMed reports Q4 earnings results
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus recommendation of "Buy" from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy rating and three hav
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus rating of "Buy" from the thirteen research firms that are currently covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a buy recommendation and three have assigned a
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (MNMD) Expected to Announce Quarterly Earnings on Thursday
Mind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=668364)
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (MNMD) Expected to Announce Earnings on Wednesday
Mind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=668364)
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Here's Why
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Should You Sell?
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Time to Sell?
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Should You Sell?
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on Wednesday
Mind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Wednesday, February 26.
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What Happened
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What Happened
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?
Why Mind Medicine Stock Is Skyrocketing Today
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 9% - Should You Sell?
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 9% - Time to Sell?
Mind Medicine (MindMed) Inc. stock logo
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been given an average rating of "Buy" by the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy recommendation and three hav
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?
Mind Medicine (MNMD) Gets a Buy from H.C. Wainwright
Mind Medicine trading higher after zerohedge compares to Oklo
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - What's Next?
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 5.5% Higher - What's Next?
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading Volume - What's Next?
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Brokerages
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus recommendation of "Buy" from the thirteen research firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and three have
Mind Medicine (MindMed) Inc. stock logo
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?
Mind Medicine (MindMed) Inc. stock logo
Analysts Issue Forecasts for MNMD FY2029 Earnings
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Friday, January 31st. HC Wainwright analyst P. Trucchio forecasts that the company w
H.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)
Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.

MNMD Media Mentions By Week

MNMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MNMD
News Sentiment

1.24

0.73

Average
Medical
News Sentiment

MNMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MNMD Articles
This Week

4

3

MNMD Articles
Average Week

Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:MNMD) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners